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INTRODUCTION
Primary cardiac tumours in the paediatric population are very rare and occur with a frequency from 0.01% to 0.04% [3, 10] . The overwhelming majority are benign and 45-58% of heart tumours in children are rhabdomyoma [1, 7] . Less common tumours in children are fibroma, angioma and teratoma [1] . Myxoma, the most common primary cardiac tumour in adults, is very rare in the paediatric population. The diagnosis of rhabdomyoma in a child is associated with 75-80% risk of tuberous sclerosis [2, 14] . Tuberous sclerosis complex (TSC) is a genetic disease first described by Bourneville, a French neurologist, in 1880. TSC is caused by mutations in the TSC1 gene (chromosome 9th) which code for Hamartin or TSC2 gene (chromosome 16th) which code for Tuberine. It is characterised with numerous changes of hamartoma-type located in the brain, kidneys, skin and other organs and manifests itself with characteristic symptoms such as epilepsy, mental retardation, and skin lesions. Over two-thirds of infants with TSC present rhabdomyoma in the heart [4] . Rhabdomyoma tumour is a major feature in the diagnosis of TSC [9] . Macroscopically, these are uniform, round tumours with a lighter shade than a healthy cardiac muscle. The microscopically pathogenic feature of rhabdomyoma is the presence of spider cells with centrally placed cytoplasm containing the nucleus and myofibrils radiating to the cell wall. Rhabdomyomas exhibit immunoreactivity with the muscle markers desmin, actin, myoglobin, vimentin, hamartin and tuberin. Immunohistochemical studies showed that the spider cells exhibit immunoreactivity with ubiquitin [15] . The changes are localised in 94% in the ventricles and may be clinically asymptomatic; however, in some cases they can lead to a heart failure, arrhythmias and death [6, 11] . Rhabdomyoma is a benign tumour, with no tendency to infiltrate neighbouring structures. The possible location of the tumour is a cardiac conduction system, where by pressure on neighbouring tissues, the tumour may manifest clinically as a conduction block and lead to death [12] . A characteristic feature of rhabdomyoma is a tendency to involution and a total regression of changes until 2 years of age is observed in 75-80% of affected children [5] . However, cardiological disorders are one of the leading causes of death in patients with TSC in the first decade of life. In symptomatic patients, the treatment option is a cardiac surgery; however, there is a high risk of mortality [5] . Over recent years, more than dozen case reports of tumour regression after the application of the mTOR inhibitor Everolimus have been published [8, 13] .
We present a case of a child with giant heart tumours (rhabdomyoma) in the course of TSC. According to the best of our knowledge, these are one of the largest tumours described in the literature.
CASE REPORT
The newborn with prenatally diagnosed (ultrasonography and magnetic resonance imaging exams) multiple tumours of the heart and brain lesions characteristic of TSC underwent a cardiologic consultation immediately after the birth. The neonate was clinically asymptomatic.
Echocardiography revealed normal ejection fraction and left ventricular size (LVIDd 17 mm) and confirmed the presence of multiple cardiac tumours, the largest in the apex of the dimensions of 33 × 30 mm, two smaller in the interventricular septum with dimensions of 14 × 11 mm and 9 × 5 mm and a few small ones in the free wall of right and left ventricle (Figs. 1, 2) . There was no evidence of obstruction of both the inflow and the outflow track of the heart. The right ventricle pressure was increased up to 70 mmHg, measured from the tricuspid regurgitation.
Several electrocardiogram (ECG) examinations showed generalised repolarisation abnormalities (Fig. 3 ). There were no arrhythmias on the 24 h Holter-ECG monitoring and on telemonitoring. The laboratory tests revealed normal level of B-type natriuretic peptide and the troponin level increased up to 22× upper limit of hospital laboratory reference range for adults. Because of the normal global ejection fraction and the lack of therapeutic options at that time, the coronary angiography was not performed. The normalisation of levels of troponin at 8 weeks of age was documented.
During the 3 months of follow-up the elevated pressure in the right ventricle was present in echocardiographic exams. Because of this, the chest angiocomputed tomography was performed (Fig. 4) and it showed no obstructions in the runoff from the pulmonary veins to the left atrium. In the subsequent echocardiographic studies the normalisation of the pressure in the right ventricle was observed. During half year of the follow-up, the child remained asymptomatic.
CONCLUSIONS
An asymptomatic neonate with multiple huge cardiac tumours requires a close follow-up with serial imaging and electrocardiography because of the risk of a sudden and unsuspected death in this group of patients. A spontaneous resolution of the rhabdomyomas may occur in children with the confirmed diagnosis of tuberous sclerosis.
